Powder: -20°C for 3 years | In solvent: -80°C for 1 year
2′,2′-Difluorodeoxyuridine (dFdU) is the major metabolite of Gemcitabine.2′,2′-Difluorodeoxyuridine has anticancer and antitumor activity, and shows radiosensitization under hypoxic conditions, and can be used to study pancreatic cancer.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 34.00 | |
10 mg | In stock | $ 48.00 | |
25 mg | In stock | $ 77.00 | |
50 mg | In stock | $ 109.00 | |
100 mg | In stock | $ 163.00 |
Description | 2′,2′-Difluorodeoxyuridine (dFdU) is the major metabolite of Gemcitabine.2′,2′-Difluorodeoxyuridine has anticancer and antitumor activity, and shows radiosensitization under hypoxic conditions, and can be used to study pancreatic cancer. |
Synonyms | dFdU, 2',2'-Difluoro-2'-deoxyuridine |
Molecular Weight | 264.18 |
Formula | C9H10F2N2O5 |
CAS No. | 114248-23-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 80 mg/mL (302.82 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
2′,2′-Difluorodeoxyuridine 114248-23-6 Metabolism Drug Metabolite dFdU 2',2'-Difluoro-2'-deoxyuridine inhibitor inhibit